Next Article in Journal
Probing Steroidal Substrate Specificity of Cytochrome P450 BM3 Variants
Next Article in Special Issue
In Vitro Reversible and Time-Dependent CYP450 Inhibition Profiles of Medicinal Herbal Plant Extracts Newbouldia laevis and Cassia abbreviata: Implications for Herb-Drug Interactions
Previous Article in Journal
A New Xanthone Glycoside from the Endolichenic Fungus Sporormiella irregularis
Previous Article in Special Issue
In Vitro Activity of Selected West African Medicinal Plants against Mycobacterium ulcerans Disease
Article Menu
Issue 6 (June) cover image

Export Article

Molecules 2016, 21(6), 765; doi:10.3390/molecules21060765

A New Alkamide with an Endoperoxide Structure from Acmella ciliata (Asteraceae) and Its in Vitro Antiplasmodial Activity
Departamento de Ciências Farmacêuticas, Centro de Ciências da Saúde, Bloco J/K, Universidade Federal de Santa Catarina, Florianópolis 88040-900, SC, Brazil
Institut für Pharmazeutische Biologie und Phytochemie (IPBP), University of Münster, PharmaCampus, Corrensstraße 48, Münster D-48149, Germany
Departamento de Química, Universidade Federal do Paraná, Curitiba 81530-900, PR, Brazil
Swiss Tropical and Public Health Institute (Swiss TPH), Socinstr. 57, Basel CH-4051, Switzerland
University of Basel, Petersplatz 1, Basel CH-4003, Switzerland
Authors to whom correspondence should be addressed.
Academic Editor: Dereck J. McPhee
Received: 12 May 2016 / Accepted: 2 June 2016 / Published: 11 June 2016


From the aerial parts of Acmella ciliata (H.B.K.) Cassini (basionym Spilanthes ciliata Kunth; Asteraceae), three alkamides were isolated and identified by mass- and NMR spectroscopic methods as (2E,6E,8E)-N-isobutyl-2,6,8-decatrienamide (spilanthol, (1)), N-(2-phenethyl)-2E-en-6,8-nonadiynamide (2) and (2E,7Z)-6,9-endoperoxy-N-isobutyl-2,7-decadienamide (3). While 1 and 2 are known alkamides, compound 3 has not been described until now. It was found that the unusual cyclic peroxide 3 exists as a racemate of both enantiomers of each alkamide; the 6,9-cis- as well as the 6,9-trans-configured diastereomers, the former represents the major, the latter the minor constituent of the mixture. In vitro tests for activity against the human pathogenic parasites Trypanosoma brucei rhodesiense and Plasmodium falciparum revealed that 1 and 3 possess activity against the NF54 strain of the latter (IC50 values of 4.5 and 5.1 µM, respectively) while 2 was almost inactive. Compound 3 was also tested against multiresistant P. falciparum K1 and was found to be even more active against this parasite strain (IC50 = 2.1 µM) with considerable selectivity (IC50 against L6 rat skeletal myoblasts = 168 µM).
Acmella ciliata; jambu; Asteraceae; antiplasmodial activity; alkamide; endoperoxide; Plasmodium falciparum

1. Introduction

Acmella ciliata (H.B.K.) Cassini (basionym: Spilanthes ciliata Kunth; Asteraceae) is a herb native to tropical regions of South America [1]. Known under the common name jambu in Brazil, it is used as a spice and in traditional medicine for the treatment of toothaches and is the active ingredient in the herbal medicinal product Spolera® used to treat abrasions and distortions [2]. Previous investigations have been carried out with this species that led to the isolation of several alkylamides (alkamides) [3,4], including the well-known bioactive isobutylamide spilanthol responsible for analgesic [5], anti-inflammatory [6] and antimalarial [7] in vitro activities.
The closely related species Acmella oleracea (L.) R. K. Jansen (basionym: Spilanthes oleracea; synonym: Spilanthes acmella var. oleracea) is widely used as spice for food and in folk medicine for stomatitis, cold and toothaches and is one of the plants constituting the traditional African antimalarial drug “Malarial-5” [8].
Malaria is a disease caused by various Plasmodium species and represents a public health problem causing many hundreds of thousands of deaths per year, especially to people living under poor circumstances and in vulnerable communities in tropical countries. According to the latest available data, an estimated 214 million cases occurred and the disease killed about 438,000 people in 2015 [9]. In this way, WHO recommends artemisinin-based combination therapies (ACTs) as the first line treatment of uncomplicated malaria caused by the P. falciparum parasite. However, since 2006, after the first artemisinin-resistant case was noticed in Cambodia, the resistance to artemisinin-derived drugs has become a global concern [10]. Therefore, the search for new antimalarial drugs has received increasing attention, including natural products. In a recent study, several alkamides from Achillea ptarmica (Asteraceae) were found to be active against Plasmodium falciparum and some other unicellular eukaryotic parasites such as Trypanosoma brucei rhodesiense, responsible for East African Human Trypanosomiasis [11]. Hence, an investigation of further alkamide-containing Asteraceae for alkamides with activity against such pathogens was of interest. Therefore, in the present investigation, we concentrated on alkamides of Acmella ciliata with potential activity against the mentioned parasites.

2. Results and Discussion

2.1. Isolation and Characterization of Alkamides

The hexane fraction of the ethanol extract from the fresh aerial parts of Acmella ciliata afforded, besides the well-known isobutylamide spilanthol ((2E,6E,8E)-N-isobutyl-2,6,8-decatrienamide, (1) and a further known compound N-(2-phenethyl)-2E-en-6,8-nonadiynamide (2), one new alkamide (2E,7Z)-6,9-endoperoxy-N-isobutyl-2,7-decadienamide (3) (Figure 1). Their chemical structures were fully established on the bases of 1D and 2D NMR and high-resolution mass spectrometric (HR-MS) data.
Compound 1 was obtained as a green oil and identified as spilanthol by comparison of its spectral data with those described in the literature [12].
Compound 2 was obtained as a yellow oil. It was previously isolated from A. ciliata [4] and its chemical structure was confirmed by comparison of the mass and 1H-NMR spectroscopic data with those reported in the literature.
Compound 3 was also obtained as a yellow oil. The +ESI QqTOF mass spectrum obtained under UHPLC coupling allowed establishment of the elemental formula as C14H23NO3 ([M + H]+ at m/z 254.1759, [M + Na]+ at m/z 276.1574; calcd. 254.1751 and 276.1570, respectively). While the isolate yielded one sharp peak in the UHPLC/MS chromatogram, it was found to show NMR signals of two very similar isomeric forms (ratio of approximately 3:1) in which most signals resonated at very similar or identical shift values with few exceptions. Nevertheless, the chemical shifts in the proton spectrum, even in parts of the spectrum with strong signal overlap, could all be determined with the help of a 2D J-resolved 1H-NMR experiment and all 1H/1H-coupling constants became accessible by selective homonuclear decoupling measurements. The NMR spectra (Table 1 and Table 2) showed the presence of an isobutylamide moiety with 1H signals at δ 3.14 (2H, H-1’), 1.80 (1H, H-2’) and 0.92 (6H, H-3’ and H-4’) and 13C resonances at δ 46.8 (C-1’), 28.5 (C-2’) and 20.1 (C-3’, C-4’) for the amine component as well as the amide carbonyl at 166.0 ppm (C-1), the latter correlated with the proton signal at δ 3.14 ppm in the HMBC spectrum (key HMBC correlations are summarized in Figure 2).
Two proton signals at δ 5.82 (1H, H-2) and 6.81 (1H, H-3) with a coupling constant of 15.2 Hz were attributed to an E-configured double bond. Their chemical shift values as well as the correlations observed in the HSQC and HMBC experiments showed that this double bond is in the direct neighborhood of the amide carbonyl, i.e., that it is part of an α,β-unsaturated amide group such as that also observed in 1 and 2. Further HMBC correlations of the two mentioned olefinic protons were observed with the methylene carbons at δ 27.9 (C-4) and 31.5 (C-5). The 1H resonances of two protons at an additional double bond were observed at δ 5.83 (H-7) and 5.86 (H-8), with a coupling constant of 10.3 Hz, indicating a Z-configuration. The corresponding olefinic carbon signals were observed at δ 127.0 and 129.3, respectively. Apart from the aforementioned signals, the 1H-NMR spectrum presented signals at δ 4.38 and 4.66 correlated according to the HSQC spectrum with carbon resonances at δ 77.2 (C-6) and 74.3 (C-9) in the 13C-NMR spectrum. These signals clearly show the presence of two oxygenated sp3 carbons in the structure. From the HMBC correlations it became clear that both of these carbons are direct neighbors of the Z-configured double bond, the former showing further correlations with the methylene signals of positions 4 and 5, the latter with a methyl group (position 10) resonating at δ 1.23 in the 1H- and at 18.1 ppm in the 13C-NMR spectrum.
The signals of the protons and carbons especially at this structural fragment (i.e., positions 6–10) appeared to have shifted between the major and minor components (see below).
These NMR data were similar to those described for longipenamide B (N-isobutyl-syn-6,9-dihydroxy-2E,7E-decadienamide) known from Heliopsis longipes [14] which, however, has an elemental formula of C23H25NO3, i.e., one degree of unsaturation less than the compound described here. Longipenamide B possesses an E-configured double bond between C-7 and C-8 and free hydroxy groups at C-6 and C-9. The lack of two hydrogen atoms in comparison with longipenamide B, together with the Z-configuration of the double bond indicated the presence of a cyclic structure in this part of the molecule which could then either be a dihydrofuran system, requiring the presence of one free hydroxy group, or a dihydro-1,2-dioxine system, i.e., a cyclic peroxide structure. Since no HMBC correlations were observable either in chloroform-d3 or in acetone-d6 between the protons and carbons at positions 6 and 9, which would be expected in case of a furanoid system, the compound was indeed assigned the depicted structure of (2E,7Z)-6,9-endoperoxy-N-isobutyl-2,7-decadienamide. The observation that especially the NMR signals for the fragment between C-6 and C-10 were shifted between the major and minor isomers pointed towards the presence of two stereoisomers, i.e., that one represents the cis-, the other the trans-configured form with respect to the asymmetric carbons, C-6 and C-9. It might be expected that the cis-oriented protons in the former would show an NOE correlation, as was previously described for a similar endoperoxide from Zanthoxylum [15]. However, NOEs could not be observed in the 2D NOESY spectrum for either isomer so that the relative stereochemistry could not be clarified in this manner. As mentioned above, the NMR signals of the protons around the endoperoxide ring showed significant shift differences in the minor isomer with H-6 being shifted downfield most prominently for Δδ 0.21 ppm, in comparison to the major isomer. Since no directly comparable data exist in literature, molecular modeling using quantum mechanical calculations had to be applied to assign the relative configuration for the major and minor isomers. To this end, the NMR shift values were calculated for geometry optimized models of the energetically most favorable conformers of both diastereomers (6R,9R-trans and 6S,9R-cis) of the de-alkylated carboxamide part of 3 (the isobutyl moiety was omitted to save computation time). The geometry optimized models were energy minimized with the B3LYP density functional and the 6-31++G(2d,p) basis set. The NMR shifts were calculated using the GIAO method at the same level of theory.
As reported in Table 3, the shift differences resulting for the cis- and trans-diastereomers were in good qualitative agreement with the major (3a) and minor isomers (3b), respectively, of compound 3. The formation of 3 (see Figure 3) is most likely to result from addition of a molecule of singlet oxygen to the diene moiety of the E,E-isomer of spilanthol (1) in case of the major isomer 3a, and to 1 itself in case of the minor isomer 3b. Light-induced isomerization of the 6,7-Z-8,9-E diene of 1 to the (energetically more favorable) E,E-isomer is in agreement with earlier literature reports on peroxidation of unsaturated fatty acids [15]. In order to evaluate whether compound 3 is a genuine product of the plant’s metabolism or formed during the extraction process, the fresh aerial parts (50 g) of A. ciliata were macerated with chloroform (100 mL) for 2 h in a flask protected from light with aluminum foil. The chloroform extract was dried in vacuo and its acetonitrile solution was then subjected to UPLC-ESI-MS analysis. Moreover, fresh flowers and leaves were quickly pounded and the resulting juices were probed by ASAP (Atmospheric solid analysis probe) MS performed according to established protocols as reported previously, e.g., in [16]. Both experiments displayed the pseudo-molecular ion m/z 254.1759 corresponding to 3 so that its formation is likely to occur already in the living plant to some extent. The structure was further supported by MS2 fragmentation as depicted in Figure 4. Taken together, it is suggested that addition of 1O2 proceeds in an uncatalyzed spontaneous manner. This reaction is possible by means of a 1,4-cycloaddition [17], so that the oxygen is added from either face of the molecules with equal probability (see Figure 3). Therefore, racemates should result in both cases. Indeed, the isolated mixture 3 was devoid of optical activity (no CD cotton effects between 450 and 190 nm) so that this result is in agreement with the postulated means of formation. It can thus be concluded that 3 is actually a mixture of all four possible stereoisomers with the 6R,9S- and 6S,9R-cis enantiomers present as major (3a, approximately 40% each) and the 6R,9R- and 6S,9S-enantiomers as the minor constituents (3b, approx. 10% each). Similar alkamides with an endoperoxide bridge have previously been described by Devkota et al. [15] as constituents of a Zanthoxylum species. However, the structure described here is a new natural product and has also not been described as a synthetic product, to the best of our knowledge. For this new compound, we propose the name dioxacmellamide.

2.2. In Vitro Antiplasmodial Activity of Isolated Alkamides

As part of our ongoing efforts to find new compounds with activity against “protozoan” parasites causing neglected tropical diseases as well as malaria, the isolated alkamides were tested for activity against Trypanosoma brucei rhodesiense (Tbr) and Plasmodium falciparum (Pf) as well as for cytotoxicity against mammalian cells (L6 cell line) using established protocols [18]. The resulting IC50 values for in vitro growth inhibition are reported in Table 4. While compound 2 displayed only insignificant activity against either parasite, compounds 1 and 3 were somewhat more active against Tbr and, especially Pf (chloroquine sensitive NF54 strain). In case of 1, antiplasmodial activity at a comparable activity level against strains PFB and K1 of Pf had already been reported [7]. Compound 3, due to its new endoperoxide structure that is related to the most important structure element of the potent antimalarial artemisinin, was also tested against the multi-resistant K1 strain of Pf where it displayed even higher activity than against the sensitive strain with an IC50 value of 0.54 µg/mL (2.1 µM) and showed considerable selectivity, i.e., very low cytotoxicity against the L6 cells (S.I. = 78.7). Compound 3 thus appears to be an interesting candidate for in vivo tests against plasmodial infections which are warranted after isolation of larger quantities.

3. Materials and Methods

3.1. General Procedures

Silica gel 60 and Sephadex® LH-20 (GE Healthcare, Uppsala, Sweden) were used for column chromatography, while silica gel 60 F254 aluminum sheets (Silicycle®, Ville de Québec, QC, Canada) were used for analytical thin layer chromatography (TLC). Compounds were visualized by exposure under UV254/365 light and by spraying with p-anisaldehyde reagent followed by heating. All solvents for chromatographic procedures were of analytical grade, while those for MS analysis were of spectrometric grade. NMR experiments were acquired at 303 K in CDCl3 and acetone-d6 on a Bruker (Billerica, MA, USA) AVANCE III NMR spectrometer and on an Agilent (Santa Clara, CA, USA) DD2 600 spectrometer, operating at 14.1 Tesla, observing 1H and 13C at 600 and 150 MHz, respectively. High-resolution MS and MS/MS analysis of the pure compounds were performed on a Bruker MicrOTOF-QII ESI-QTOF mass spectrometer coupled to a Dionex (Sunnyvale, CA, USA) Ultimate 3000 RS UHPLC. LC-MS and MS analyses of CHCl3 extract and the plant material were carried on a Waters (Milford, MA, USA) Xevo G2-S QTOF mass spectrometer equipped with exchangeable ESI and ASAP sources and coupled to an Acquity UPLC (Waters) chromatograph. A CD spectrum of 3, recorded in MeOH on a Jasco (Groß-Umstadt, Germany) J815 spectropolarimeter, did not show any cotton effects.

3.2. Botanical Material

Aerial parts of Acmella ciliata (H.B.K.) Cassini were collected at the garden of the Associação dos Funcionários Fiscais do Estado de Santa Catarina (AFFESC, Florianópolis, Santa Catarina, Brazil) in October, 2012. The plant material was identified by Dr. Marcos Sobral and a voucher specimen was deposited in the Herbarium of the Botanic Garden of Rio de Janeiro under reference RB 612273.

3.3. Extraction and Isolation

A summary of the isolation procedure for compounds 13 is shown in Figure 5. Aerial parts of fresh plant (1754 g) were washed with water, air dried and macerated for 3 × 7 days with ethanol 92% (total volume 8 L) at room temperature. The crude extract was filtered and concentrated under reduced pressure at 40 °C, yielding 60.9 g of crude ethanol extract. The extract was then dispersed in water and partitioned with solvents of increasing polarity: n-hexane (24.4 g), followed by CH2Cl2 (0.8 g), and EtOAc (1.6 g), and the residual aqueous fraction was freeze-dried.
The hexane fraction (22.7 g) was initially fractionated by VLC packed with silica gel 60 (particle size 40–63 µm) (Column A) and eluted with gradient solvent systems of n-hexane/acetone in increasing polarities (100:0 (350 mL), 90:10 (300 mL), 80:20 (400 mL), 70:30 (400 mL), 60:40 (600 mL), 40:60 (300 mL), 20:80 (200 mL), 0:100 (300 mL), respectively), yielding 13 sub-fractions. Sub-fraction A4 (4.8 g) was subjected to a silica gel 60 (particle size 40–63 µm) column chromatography (Column B) and eluted with gradient solvent systems of n-hexane/acetone in increasing polarity (100:0 (200 mL), 98:02 (100 mL), 95:05 (500 mL), 92:08 (300 mL), 90:10 (100 mL), 85:15 (400 mL), 80:20 (100 mL), 70:30 (200 mL), 60:40 (100 mL), 0:100 (100 mL), respectively), yielding 48 sub-fractions. The sub-fractions B18–B27 (1.2 g) were submitted to another silica gel 60 (particle size 40–63 µm) column chromatography (Column C) and eluted with gradient solvent systems of n-hexane/acetone in increasing polarity (100:0 (50 mL), 95:05 (100 mL), 90:10 (50 mL), 80:20 (50 mL), 75:25 (100 mL), 60:40 (100 mL), 50:50 (50 mL), 40:60 (100 mL), 0:100 (50 mL), respectively), yielding 18 sub-fractions. Compound 1 was obtained from sub-fractions C7–C8 (104.7 mg, green oil) and compound 3 was obtained from sub-fractions C11–C12 (35.5 mg, yellow oil). Sub-fraction A6 (414 mg) from Column A was subjected to a silica gel 60 (40–63 µm) column chromatography (Column D) and eluted with gradient solvent systems of n-hexane–acetone in increasing polarity (80:20 (500 mL), 70:30 (200 mL), 0:100 (50 mL), respectively), yielding 25 sub-fractions. The sub-fractions D11–D13 (48.4 mg) were submitted to a Sephadex LH20 column chromatography (Column E) and eluted with methanol yielding 16 sub-fractions. Compound 2 was obtained from subfraction E7 (13.5 mg, yellow oil). All sub-fractions were monitored by analytical TLC on silica gel 60 F254 aluminum sheets using n-hexane:acetone (6:4; v/v) as mobile phase; detection was performed at daylight, 366 and 254 nm, and after spraying with p-anisaldehyde reagent followed by heating. The fractionation and isolation process is summarized in Figure 4.

3.4. Biological Activity Tests

In vitro tests for activity against T. brucei rhodesiense (bloodstream trypomastigotes, strain STIB 900) and P. falciparum (intraerythrosctic forms, strains NF54 and K1) as well as for cytotoxicity against mammalian cells (L6 rat skeletal myoblasts) were performed according to established protocols as reported previously, e.g., in [18].

3.5. Molecular Modeling and NMR Shift Calculations for Compound 3

All calculations were performed with molecular models of the dealkylated carboxamide part of 3, i.e., the isobutyl residue was omitted in order to save computation time. A molecular model of each, the 6S,9R-cis- and the 6R,9R-trans- diastereomer was generated with the software package MOE [19] and submitted to a low-mode molecular dynamics conformational search using the MMFF94x force field and standard settings. The energetically lowest conformer of each stereoisomer found in these searches was energy-minimized with Gaussian 03W [20] using the B3LYP density functional and the 6-31G++(2d,p) basis set. Subsequently, the NMR shielding tensors were computed with the same software and at the same level of theory using the GIAO formalism. A molecule of tetramethylsilane was treated in the same manner in order to obtain the reference value (34.9441 ppm). Chemical shift values were obtained by subtracting the TMS reference value from the values calculated for the protons mentioned in Table 1.

4. Conclusions

The search for alkamides with anti-protozoal activity in the medicinal plant Acmella ciliata has resulted in the discovery of dioxacmellamide (3), a new alkamide with cyclic peroxide structure which shows considerable in vitro activity against P. falciparum with selectivity against the multiresistant K1 strain. It is very likely that this interesting compound is formed by 1,4-cycloaddition of oxygen to the diene moiety of the plant product spilanthol, and it could also be demonstrated that it can easily be obtained from the latter. This accessibility from the main constituent spilanthol will enable us to obtain larger quantities for in vivo tests and detailed studies of the mechanism of action of this new anti-plasmodial hit molecule. Such studies have been initiated.

Supplementary Materials

MS and NMR spectra of 3 as well as details on the MS analyses are available online at:


The authors thank CNPq and CAPES for the financial support and the scholarships. The authors also thank Professor Marcos Sobral for the identification of plant material and Associação dos Funcionários Fiscais do Estado de Santa Catarina (AFFESC) for providing the plant material. TJS gratefully acknowledges financial support from Apothekerstiftung Westfalen-Lippe. Parts of this study are an activity of MWB, TJS, LPS and RB within the Research Network Natural Products against Neglected Diseases (ResNet NPND,

Author Contributions

N.S. (doctorate student) contributed in collecting the plant material, phytochemical investigation, elucidation of compounds, data analyses and drafted the paper. J.S. (undergraduate student of the University of Münster) contributed in performing part of the laboratory work during a pharmacy practice internship at the UFSC laboratories. A.D.C.S. (doctorate student) performed some of the NMR measurements. A.B. contributed to NMR analyses and elucidation of compounds. L.P.S. contributed to L.C.M.S. analyses and elucidation of compounds. R.B. and M.K. performed the biological activity tests. M.W.B. supervised the laboratory work, data analyses and contributed to finalization of the manuscript. T.J.S. initiated the study, obtained and analyzed NMR spectra of compound 3, performed LC-MS analysis and finalized the manuscript together with M.W.B.

Conflicts of Interest

The authors declare no conflict of interest.


  1. Jansen, R.K. The systematics of Acmella (Asteraceae-Heliantheae). Syst. Bot. Monogr. 1985, 8, 115. [Google Scholar] [CrossRef]
  2. Kasper, J.; Melzig, M.F.; Jenett-Siems, K. New phenolic compounds of Acmella ciliata. Planta Med. 2010, 76, 633–635. [Google Scholar] [CrossRef] [PubMed]
  3. Martin, R.; Becker, H. Spilanthol-related amides from Acmella ciliata. Phytochem. 1984, 23, 1781–1783. [Google Scholar] [CrossRef]
  4. Martin, R.; Becker, H. Amides and other constituents from Acmella ciliata. Phytochem. 1985, 24, 2295–2300. [Google Scholar] [CrossRef]
  5. Rios, M.Y.; Guadarrama, A.B.A.; Gutiérrez, M.C. Analgesic activity of affinin, an alkamide from Heliopsis longipes (Compositae). J. Ethnopharmacol. 2007, 110, 364–367. [Google Scholar] [CrossRef] [PubMed]
  6. Wu, L.C.; Fan, N.C.; Lin, M.H.; Chu, I.R.; Huang, H.J.; Hu, C.Y.; Han, S.Y. Anti-inflammatory effect of spilanthol from Spilanthes acmella on murine macrophage by down-regulating LPS-induced inflammatory mediators. J. Agric. Food Chem. 2008, 56, 2341–2349. [Google Scholar] [CrossRef] [PubMed]
  7. Spelman, K.; Depoix, D.; McCray, M.; Mouray, E.; Grellier, P. The traditional medicine Spilanthes acmella, and the alkylamides spilanthol and undeca-2E-ene-8,10-diynoic acid isobutylamide, demonstrate in vitro and in vivo antimalarial activity. Phytother. Res. 2011, 25, 1098–1101. [Google Scholar] [CrossRef] [PubMed]
  8. Gasquet, M.; Delmas, F.; Timon-David, P.; Keita, A.; Guindo, M.; Koita, N.; Diallo, D.; Doumbo, O. Evaluation in vitro and in vivo of a traditional antimalarial, “Malarial 5”. Fitoterapia 1993, 64, 423–426. [Google Scholar]
  9. World Health Organization. World Malaria Report 2015. Available online: (accessed on 26 May 2016).
  10. Kong, L.Y.; Tan, R.X. Artemisinin, a miracle of Traditional Chinese Medicine. Nat. Prod. Rep. 2015, 32, 1617–1621. [Google Scholar] [CrossRef] [PubMed]
  11. Althaus, J.B.; Kaiser, M.; Brun, R.; Schmidt, T.J. Antiprotozoal activity of Achillea ptarmica (Asteraceae) and its main alkamide constituents. Molecules 2014, 19, 6428–6438. [Google Scholar] [CrossRef] [PubMed]
  12. Nakatani, N.; Nagashima, M. Pungent alkamides from Spilanthes acmella L. var oleracea Clarke. Biosci. Biotechnol. Biochem. 1992, 56, 759–762. [Google Scholar] [CrossRef]
  13. Constantino, M.G.; Silva, G.V.J.; Heleno, V.C.G.; Borin, I.A. Simulação de desdobramentos complexos de espectros de RMN de 1H. Quim. Nova 2006, 29, 160–167. [Google Scholar] [CrossRef]
  14. Martínez, S.L.; Guadarrama, A.B.A.; Rios, M.Y. Minor alkamides from Heliopsis longipes S.F. Blake (Asteraceae) fresh roots. Phytochem. Lett. 2011, 4, 275–279. [Google Scholar] [CrossRef]
  15. Devkota, K.P.; Wilson, J.; Henrich, C.J.; McMahon, J.B.; Reilly, K.M.; Beutler, J.A. Isobutylhydroxyamides from the pericarp of nepalese Zanthoxylum armatum inhibit NF1-defective tumor cell line growth. J. Nat. Prod. 2013, 76, 59–63. [Google Scholar] [CrossRef] [PubMed]
  16. McEwen, C.N.; McKay, R.G.; Larsen, B.S. Analysis of solids, liquids, and biological tissues using solids probe introduction at atmospheric pressure on commercial LC/MS instruments. Anal. Chem. 2005, 77, 7826–7831. [Google Scholar] [CrossRef] [PubMed]
  17. Neff, W.E.; Frankel, E.N. Photosensitized oxidation of methyl linolenate monohydroperoxides: Hydroperoxy cyclic peroxides, dihydroperoxides and hydroperoxy bis-cyclic peroxides. Lipids 1984, 19, 952–957. [Google Scholar] [CrossRef]
  18. Schmidt, T.J.; Nour, A.M.M.; Khalid, S.A.; Kaiser, M.; Brun, R. Quantitative structure-antiprotozoal activity relationships of sesquiterpene lactones. Molecules 2009, 14, 2062–2076. [Google Scholar] [CrossRef] [PubMed]
  19. Molecular Operating Environment (MOE); 2013.08; Chemical Computing Group Inc.: Montreal, QC, Canada, 2016.
  20. Frisch, M.J.; Trucks, G.W.; Schlegel, H.B.; Scuseria, G.E.; Robb, M.A.; Cheeseman, J.R.; Montgomery, J.A., Jr.; Vreven, T.; Kudin, K.N.; Burant, J.C.; et al. Gaussian 03, Revision B.05; Gaussian, Inc.: Wallingford, CT, USA, 2004. [Google Scholar]
  • Sample Availability: Samples of the compounds 13 are available from the authors.
Figure 1. Structures of the isolated alkamides.
Figure 1. Structures of the isolated alkamides.
Molecules 21 00765 g001 1024
Figure 2. Key HMBC correlations for compound 3.
Figure 2. Key HMBC correlations for compound 3.
Molecules 21 00765 g002 1024
Figure 3. Hypothetical routes of formation for the stereoisomers of compound 3.
Figure 3. Hypothetical routes of formation for the stereoisomers of compound 3.
Molecules 21 00765 g003 1024
Figure 4. Proposed fragmentation mechanism of the endoperoxide alkamide (m/z 254).
Figure 4. Proposed fragmentation mechanism of the endoperoxide alkamide (m/z 254).
Molecules 21 00765 g004 1024
Figure 5. Flow chart for the isolation of the compounds 13.
Figure 5. Flow chart for the isolation of the compounds 13.
Molecules 21 00765 g005 1024
Table 1. 1H-NMR data (CDCl3, 600 MHz) for compounds 3a and 3b.
Table 1. 1H-NMR data (CDCl3, 600 MHz) for compounds 3a and 3b.
δH, Mult. (J in Hz)δH, Mult. (J in Hz)
25.82 ddd (15.2, 1.4 and 1.4)5.82 ddd (15.2, 1.4 and 1.4)
36.81 ddd (15.2, 7.4 and 6.6)6.81 ddd (15.2, 7.4 and 6.6)
42.32 ddddd (14.9, 8.8, 7.4, 7.2 and 1.4)2.32 ddddd (14.9, 8.8, 7.4, 7.2 and 1.4)
2.36 ddddd (14.9, 9.1, 6.6, 5.3 and 1.4)2.36 ddddd (14.9, 9.1, 6.6, 5.3 and 1.4)
51.69 dddd (14.2, 9.1, 7.2 and 4.0)1.67 dddd (14.2, 9.1, 7.2 and 4.0)
1.87 dddd (14.2, 8.9, 8.8 and 5.3)1.87 dddd (14.2, 8.9, 8.8 and 5.3)
64.38 ddddd (8.9, 4.0, 2.4, 1.3 and 1.2)4.59 ddddd (8.9, 4.0, 2.4, 1.3 and 1.2)
75.83 ddd (10.3, 2.4 and 1.5)5.78 ddd (10.3, 2.4 and 1.5)
85.86 ddd (10.3, 1.7 and 1.2)5.83 ddd (10.3, 1.7 and 1.2)
94.66 qddd (6.7, 1.7, 1.5 and 1.3)4.70 qddd (6.7, 1.7, 1.5 and 1.3)
101.23 d (6.7)1.20 d (6.7)
1’3.14 dd (6.8 and 6.2)3.14 dd (6.8 and 6.2)
2’1.80 th (6.8 and 6.7)1.80 th (6.8 and 6.7)
3’0.92 d (6.7)0.92 d (6.7)
4’0.92 d (6.7)0.92 d (6.7)
The corrected multiplicities in the 1H-NMR spectra were established with the aid of FOMSC3 software [13].
Table 2. 13C-NMR data (CDCl3, 150 MHz) for compounds 3a and 3b.
Table 2. 13C-NMR data (CDCl3, 150 MHz) for compounds 3a and 3b.
1166.0 165.9
2124.4C-1, C-4124.4C-1, C-4
3143.3C-1, C-2, C-4, C-5143.2C-1, C-2, C-4, C-5
427.9C-2, C-3, C-5, C-627.5C-2, C-3, C-5, C-6
C-2, C-3, C-5, C-6C-2, C-3, C-5, C-6
531.5C-3, C-4, C-6, C-731.0C-3, C-4, C-6, C-7
C-3, C-4, C-6, C-7C-3, C-4, C-6, C-7
677.2C-4, C-5, C-7, C-876.8C-4, C-5, C-7, C-8
7127.0C-6, C-9127.2C-6, C-9
8129.3C-6, C-9129.5C-6, C-9
974.3C-7, C-8, C-1074.2C-7, C-8, C-10
1018.1C-8, C-917.7C-8, C-9
1’46.8C-1, C-2’, C-3’, C-4’46.7C-1, C-2’, C-3’, C-4’
2’28.5C-1’, C-3’, C-4’28.5C-1’, C-3’, C-4’
3’20.1C-1’, C-2’, C-4’20.1C-1’, C-2’, C-4’
4’20.1C-1’, C-2’, C-3’20.1C-1’, C-2’, C-3’
Table 3. Calculated and experimental chemical shift values and differences for protons at the endoperoxide ring of compound 3. Upfield shifts comparing the first and second columns of calculated and experimental data, respectively, are colored in blue, downfield shifts in red.
Table 3. Calculated and experimental chemical shift values and differences for protons at the endoperoxide ring of compound 3. Upfield shifts comparing the first and second columns of calculated and experimental data, respectively, are colored in blue, downfield shifts in red.
Position H-Calc. ΔΔδ CalcExp. ΔΔδ Exp
6S,9R-cis6R,9R-transMajor IsomerMinor Isomer
Table 4. In vitro antiparasitic activity IC50 values in µg/mL and cytotoxicity (L6 rat skeletal myoblasts) of alkamides 13. Mean values are also reported in µM (in brackets) for easier comparison between compounds.
Table 4. In vitro antiparasitic activity IC50 values in µg/mL and cytotoxicity (L6 rat skeletal myoblasts) of alkamides 13. Mean values are also reported in µM (in brackets) for easier comparison between compounds.
CompoundTbrPf (NF54)Pf (K1)L6
12.88 ± 0.06 (13.0)0.99 ± 0.12 (4.5)n.t.39.9 ± 1.9 (180.3)
217.1 ± 2.3 (68.1)22.1 ± 4.0 (88.0)n.t.60.1 ± 9.4 (239.2)
35.60 ± 0.67 (13.0)1.29 ± 0.20 (5.1)0.54 ± 0.14 (2.1)42.6 ± 1.7 (168.2)
Pos. contr.0.004 ± 0.001 a0.002 ± 0.001 b0.09 ± 0.006 b0.004 ± 0.001 c
a melarsoprol; b chloroquine; c podophyllotoxin.
Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top